Results 71 to 80 of about 325,675 (121)

Copy-Number Aberrations in Circulating Tumor DNA Enable Diagnosis and Risk Stratification of Pediatric Neuroblastic Tumors. [PDF]

open access: yesCancer Res Commun
Tao T   +9 more
europepmc   +1 more source

P040 | REAL-WORLD EXPERIENCE WITH BISPECIFIC ANTIBODY EPCORITAMAB IN RELAPSED/REFRACTORY DLBCL: A MULTICENTRIC RETROSPECTIVE ANALYSIS

open access: yesHaematologica
Background: Epcoritamab is approved for relapsed/refractory DLBCL from the third line onward. Pivotal trial results showed high efficacy and good safety. However, real-world data are limited, with some studies showing less favorable outcomes.
M. Porrazzo   +12 more
doaj  

P077 | EFFICACY OF VENETOCLAX ALONE AND IN COMBINATION WITH PONATINIB ACROSS MOLECULAR SUBTYPES OF ACUTE LYMPHOBLASTIC LEUKEMIA

open access: yesHaematologica
Background In adult patients (pts) with acute lymphoblastic leukemia (ALL), despite initial responses to chemotherapy or immunotherapies like inotuzumab or blinatumomab, relapse rates are high, the prognosis remains poor.
F. Lo Schiavo   +19 more
doaj  

Home - About - Disclaimer - Privacy